Sino-German “Generation Z” Uncover In-flight Meals with CEA Chefs

4 years ago

SHANGHAI--(BUSINESS WIRE)--On October 28, teachers and students from Chinese and German universities participated in the livestream activity hosted by China…

Timberland Bancorp’s Fiscal Fourth Quarter Net Income Increases 23%

4 years ago

Quarterly EPS Increases 23% to $0.85 from $0.69 for the Preceding Quarter Quarterly Return on Average Assets Increases to 1.51%…

Bitcoin.com Officially Expands Access to DeFi with Public Sale of Ecosystem Utility Token VERSE

4 years ago

Whitelisted individuals for the sale will be able to purchase VERSE tokens using BTC, BCH, ETH and USDT/USDC. SAINT KITTS…

New Vonage Study Reveals That Consumers Want Digital Interactions With Brands to Feel More Like Personal Conversations

4 years ago

Vonage 11th Annual Global Customer Engagement Report reveals technology gap prevents meaningful connections and risks loyalty among customers SINGAPORE--(BUSINESS WIRE)--Vonage,…

Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence

4 years ago

YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential YH003 in combination with PD-1 are being dosed in…

Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence

4 years ago

YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential. YH003 in combination with PD-1 are being dosed in…

Airwallex partners with University of Melbourne to forge Australia’s future tech leaders

4 years ago

MELBOURNE, Australia--(BUSINESS WIRE)--Global fintech Airwallex has embarked on a pivotal partnership with the University of Melbourne, which will help build…

Orum Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ORM-5029 in Development to Treat HER2-Expressing Advanced Solid Tumors

4 years ago

ORM-5029 is a first-in-class drug candidate designed to selectively deliver catalytic GSPT1 protein degraders to HER2-expressing tumor cells via antibody…

Lightnet Group Partners with Raffles Family Office to Expand Payment Ecosystem to Revo – Asia’s First Digital Asset-Based Multi-Family Office Platform

4 years ago

SINGAPORE - Media OutReach - 1 November 2022 - Singapore-based Lightnet Group ("Lightnet") announced today the completion of Raffles Family…

Kite Realty Group Trust Publishes Inaugural Corporate Responsibility Report

4 years ago

INDIANAPOLIS, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today the release of its inaugural…